By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Curis, Inc. 

61 Moulton Street

Cambridge  Massachusetts  02138  U.S.A.
Phone: 617-876-0086 Fax: 617-876-0866



Company News
Curis, Inc. (CRIS) To Present CUDC-907 Clinical Data At The 20th Congress Of The European Hematology Association And The 13th International Congress On Malignant Lymphoma 6/10/2015 8:16:38 AM
ASCO15: Curis, Inc. (CRIS) Reports CUDC-907 Data From The Ongoing Phase I Trial At The 2015 ASCO Annual Meeting 6/1/2015 7:31:29 AM
Curis, Inc. (CRIS) To Present At The Jefferies and Co. 2015 Healthcare Conference 5/27/2015 7:17:02 AM
Curis, Inc. (CRIS) Announces Presentations Of CUDC-907 And Erivedge(R) Clinical Data At 2015 ASCO Annual Meetin 5/20/2015 1:55:44 PM
Curis, Inc. (CRIS) Reports First Quarter 2015 Financial Results 5/7/2015 12:49:30 PM
Curis, Inc. (CRIS) To Release First Quarter 2015 Financial Results And Hold Conference Call On May 7, 2015 4/30/2015 8:23:07 AM
Curis, Inc. (CRIS) Presents Preclinical Data On CUDC-427 At AACR Annual Meeting 4/22/2015 10:46:06 AM
Curis, Inc. (CRIS) Announces Presentation Of Data From CUDC-427 And IRAK-4 Programs At American Association for Cancer Research Annual Meeting 4/15/2015 3:16:22 PM
Curis, Inc. (CRIS) Announces Orphan Drug Designation For CUDC-907 In Diffuse Large B-Cell Lymphoma 4/6/2015 7:06:53 AM
Curis, Inc. (CRIS) To Present At The 27th Annual Roth Conference 3/4/2015 8:37:36 AM